Respiratory Infections

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

A recent review of electronic health data revealed a 42% drop in emergency department visits during 4 weeks of the pandemic.

An overview of today's top infectious disease stories.

Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

In order to expand the potential uses of the drug against SARS-CoV-2, Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.

A video summary of the latest infectious disease headlines.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

A video review of the latest ID news.

Pregnant women with COVID-19 typically experienced symptoms in their second and third trimester, a new study shows.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.

In a new analysis of Guangzhou city contact tracing data, investigators examined secondary attack rates of SARS-CoV-2.

An overview of 3 recent infectious disease news stories.

Vibeke Strand, MD, MACR, FACP, discusses patients who are having a hard time getting their usual supplies of HCQ.

Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.

The technology deploys AI-based algorithms that use machine-learning to identify respiratory failure and hemodynamic instability

A look at 3 major headlines in COVID-19 news on June 15, 2020.

The anti-malaria drugs—and clinical trials assessing their benefit—have been under close scrutiny since the EUA was first granted in late March.

During the spring COVID-19 outbreak, an examination of Swiss people in Geneva shows only a small amount of the population with IgG antibodies.

Findings show states who followed stay-at-home orders indeed flattened their curves. Now what?

Analysis projects significant toll from virus, even with some measures in place.

Trending infectious disease news.

A Harvard Medical School study team sought to identify individuals at elevated risk for severe COVID-19 and, among them, those at high risk of financial ruin as a result of costs associated with their care.

Infectious disease experts have recommended that stockpiles of several promising vaccine candidates be created as they enter late stage development.

A brief on today's top ID stories.

Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.